Error: Could not add to watchlist. X

Actelion Ltd

+ Watchlist
ATLN:VX
SIX Swiss Ex
131.20
CHF
0.90
0.69%
As of 08:13:01 ET on 08/31/2015.
Open
130.40
Day Range
130.00 - 131.70
Volume
97,480
Previous Close
130.30
52Wk Range
90.42 - 147.00
1 Yr Return
17.79%
Open
130.40
Day Range
130.00 - 131.70
Volume
97,480
Previous Close
130.30
52Wk Range
90.42 - 147.00
1 Yr Return
17.79%
YTD Return
15.13%
Current P/E Ratio (TTM)
31.59
Earnings per Share (CHF) (TTM)
4.16
Market Cap (b CHF)
14.996
Shares Outstanding (m)
114.128
Price/Sales (TTM)
7.38
Dividend Indicated Gross Yield
0.99%
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech
There are currently no news stories for this ticker. Please check back later.
Profile
Actelion Ltd is a biopharmaceutical company focused on the discovery, development and commercialization of drugs for diseases with significant unmet medical needs. The Company focuses in the field of pulmonary arterial hypertension (PAH) with treatments for diseases from WHO Functional Class (FC) II through to FC IV, with oral, inhaled and intravenous medications.
ADDRESS
Gewerbestrasse 16
Allschwil, 4123
Switzerland
PHONE
41-61-565-65-65
  • Jean-Paul Clozel
    CEO/Co-Founder
  • Andre C Muller
    Exec VP/CFO
  • Otto Schwarz
    Exec VP/COO
  • Nicholas Franco
    Exec VP/Chief Bus Dev Officer
  • Guy Braunstein
    Exec VP/Head:Clinical Dev
Show More